30 results on '"Hansen, Charlotte T."'
Search Results
2. Effects of hypoglycaemia on working memory and regional cerebral blood flow in type 1 diabetes: a randomised, crossover trial
3. Clinicopathological features of plasmablastic multiple myeloma: a population-based cohort
4. Evaluation of the serum free light chain (sFLC) analysis in prediction of response in symptomatic multiple myeloma patients: rapid profound reduction in involved FLC predicts achievement of VGPR
5. Effect of laxatives on gastrointestinal functional recovery in fast-track hysterectomy: a double-blind, placebo-controlled randomized study
6. Clinical and preclinical validation of the serum free light chain assay: identification of the critical difference for optimized clinical use
7. Transfusion rate and prevalence of unexpected red blood cell alloantibodies in women undergoing hysterectomy for benign disease
8. Clinically‐suspected cast nephropathy: A retrospective, national, real‐world study
9. Timing of heparin prophylaxis and bleeding complications in hysterectomy a nationwide prospective cohort study of 9,949 Danish women
10. Establishment of a national Danish hysterectomy database: Preliminary report on the first 13,425 hysterectomies
11. Lower rates of hypoglycaemia in older individuals with type 2 diabetes using insulin degludec versus insulin glargine U100: Results from SWITCH 2
12. Cardiovascular Safety and Severe Hypoglycemia Benefit of Insulin Degludec vs. Insulin Glargine U100 in Older Patients (≥65 Years) with Type 2 Diabetes: Observations From DEVOTE
13. Insulin Degludec Has Lower Hypoglycemia Risk than Insulin Glargine U100 in Older People with Type 2 Diabetes (T2D)
14. Within-day Variability Based on 9-point Profiles Associates with Overall and Nocturnal Hypoglycemia Risk in Adults with Type 1 (T1D) or Type 2 Diabetes (T2D)
15. Insulin Degludec 200 Units/mL Is Associated With Lower Injection Frequency and Improved Patient-Reported Outcomes Compared With Insulin Glargine 100 Units/mL in Patients With Type 2 Diabetes Requiring High-Dose Insulin
16. Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (DEVOTE 7).
17. 17 - Cardiovascular Safety and Severe Hypoglycemia Benefit of Insulin Degludec vs. Insulin Glargine U100 in Older Patients (≥65 Years) with Type 2 Diabetes: Observations From DEVOTE
18. Is retention of zoledronic acid onto bone different in multiple myeloma and breast cancer patients with bone metastasis?
19. Effects of hypoglycaemia on working memory and regional cerebral blood flow in type 1 diabetes: a randomised, crossover trial.
20. Transfusion rate and prevalence of unexpected red blood cell alloantibodies in women undergoing hysterectomy for benign disease
21. 16 - Within-day Variability Based on 9-point Profiles Associates with Overall and Nocturnal Hypoglycemia Risk in Adults with Type 1 (T1D) or Type 2 Diabetes (T2D)
22. Clinicopathological features of plasmablastic multiple myeloma: a population‐based cohort
23. Risk factors for chronic pain after hysterectomy:a nationwide questionnaire and database study
24. Dosing related effects of zoledronic acid on bone markers and creatinine clearance in patients with multiple myeloma and metastatic breast cancer
25. Insulin Degludec Improves Glycemic Control with Lower Nocturnal Hypoglycemia Risk than Insulin Glargine: A 2-year Randomized Trial in Type 1 Diabetes
26. Establishment of a National Danish Hysterectomy Database: Preliminary Report on the First 13,425 Hysterectomies
27. Risk Factors for Chronic Pain after Hysterectomy
28. Dosing related effects of zoledronic acid on bone markers and creatinine clearance in patients with multiple myeloma and metastatic breast cancer.
29. Amyloidosis is a disease with many faces.
30. Is retention of zoledronic acid onto bone different in multiple myeloma and breast cancer patients with bone metastasis?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.